How a Dutch AI Startup Quietly Raised $2 Million to Transform Hearing Care

Jan de Vries · 2026-08-28

Let's talk about a quiet funding round that could make a lot of noise. And I mean that literally. There's a startup in the Netherlands that just secured $2 million in seed funding, and their mission is to change how millions of people finally get help for hearing loss. It's one of those ideas that makes you think, "Why didn't anyone do this before?" ### Meet Clementine and Their AI Agent, Matthew The company is called Clementine, based in Maastricht. They launched just this year, but they're already making waves with what they call the world's first AI hearing activation platform. The brainchild of founder and CEO Vince van de Weijer, the whole operation revolves around an AI named Matthew. Think of Matthew as a 24/7 hearing care concierge. He's not a replacement for a doctor, not by a long shot. Instead, he's that first, judgment-free conversation for someone who might be nervous, confused, or just putting things off. He answers questions any time of day, helps people understand their options, and gently guides them toward actually booking an appointment with a real clinic. For clinics drowning in phone calls and admin, that's a game-changer. Matthew handles the initial outreach, filters the inquiries, and turns vague interest into concrete bookings. It's about quality conversations, not just more leads. ### The Investor Betting on Behavioral Science The $2 million seed round was led by Healthy.Capital, an Amsterdam-based investor that specializes in early-stage health tech. They've backed other promising names like Pharmi and OpenUp, so they know what to look for. Douwe Jippes, their managing partner, put it perfectly: "Clementine combines deep domain expertise with a clear AI platform strategy that can scale globally. We believe this approach will fundamentally change how people with hearing disability engage with hearing healthcare." That last part is key. This isn't just a fancy chatbot. It's AI paired with real behavioral science. The goal is to overcome the emotional hurdles that keep people from seeking care in the first place. ### The Staggering Scale of the Problem Here's the thing that really puts this funding into perspective. The numbers are almost hard to believe. According to the company's data: - Hearing loss affects roughly 1.5 billion people worldwide. - Nearly 80% of those people never seek any treatment at all. - For the ones who do finally take action, they typically wait over eight years from when they first notice a problem. Eight years. That's a long time to struggle with something that could be managed. The barriers aren't just medical; they're psychological. There's stigma, there's confusion about options, and there's the simple dread of making that first awkward phone call. ### What's Next for Clementine? This new capital isn't for sitting around. The plan is to double down on the AI, making Matthew even smarter and more helpful. But just as importantly, they're expanding their partnerships. They've already teamed up with Zoolstra, a marketing agency that works with hearing clinics across the United States and Canada. Now, they're looking to bring more clinics, optical retailers, and other healthcare organizations into the fold. The vision is a global one. They want to create an on-ramp to hearing care that's available to anyone, anywhere, the moment they're curious enough to ask a question online. No waiting lists, no judgment, just a helpful voice named Matthew starting a conversation that could change someone's quality of life. It's a simple premise, really. Sometimes, the biggest breakthroughs in healthcare aren't about a new drug or a new surgery. Sometimes, they're just about making the path to existing care a little less daunting. And if an AI from Maastricht can do that, then that $2 million investment might just be the start of something you'll hear a lot more about.